TFF3 is a hypoxia-inducible factor that enhances HB cell proliferation, survival and chemoresistance. Its tumour-promoting activity through C-MYC and mTOR pathways identifies TFF3 as a potential therapeutic target and circulating biomarker in hepatoblastoma.
Building similarity graph...
Analyzing shared references across papers
Loading...
Luz Andrea Martínez‐Pérez
Universidad de Guadalajara
M. Ujue Latasa
Navarre Institute of Health Research
Iker Uriarte
Instituto de Salud Carlos III
Liver International
RWTH Aachen University
University of Turin
Charles University
Building similarity graph...
Analyzing shared references across papers
Loading...
Martínez‐Pérez et al. (Fri,) studied this question.
synapsesocial.com/papers/69b6068883145bc643d1c74c — DOI: https://doi.org/10.1111/liv.70592
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: